Next Article in Journal
Regulation of CTLA-4 and PD-L1 Expression in Relapsing-Remitting Multiple Sclerosis Patients after Treatment with Fingolimod, IFNβ-1α, Glatiramer Acetate, and Dimethyl Fumarate Drugs
Next Article in Special Issue
Effect of Foot Orthoses and Shoes in Parkinson’s Disease Patients: A PRISMA Systematic Review
Previous Article in Journal
Superiority of Mild Interventions against COVID-19 on Public Health and Economic Measures
Previous Article in Special Issue
Combined and Sequential Treatment with Deep Brain Stimulation and Continuous Intrajejunal Levodopa Infusion for Parkinson’s Disease
 
 
Article

Article Versions Notes

J. Pers. Med. 2021, 11(8), 720; https://doi.org/10.3390/jpm11080720
Action Date Notes Link
article pdf uploaded. 26 July 2021 16:34 CEST Version of Record https://www.mdpi.com/2075-4426/11/8/720/pdf-vor
article xml file uploaded 27 July 2021 08:50 CEST Original file -
article xml uploaded. 27 July 2021 08:50 CEST Update -
article pdf uploaded. 27 July 2021 08:50 CEST Updated version of record https://www.mdpi.com/2075-4426/11/8/720/pdf-vor
article html file updated 27 July 2021 08:52 CEST Original file -
article xml file uploaded 28 July 2021 08:08 CEST Update -
article xml uploaded. 28 July 2021 08:08 CEST Update https://www.mdpi.com/2075-4426/11/8/720/xml
article pdf uploaded. 28 July 2021 08:08 CEST Updated version of record https://www.mdpi.com/2075-4426/11/8/720/pdf
article html file updated 28 July 2021 08:10 CEST Update -
article html file updated 27 July 2022 06:37 CEST Update https://www.mdpi.com/2075-4426/11/8/720/html
Back to TopTop